U.S. markets open in 4 hours 42 minutes
  • S&P Futures

    4,131.00
    +24.00 (+0.58%)
     
  • Dow Futures

    34,091.00
    +153.00 (+0.45%)
     
  • Nasdaq Futures

    13,208.50
    +108.25 (+0.83%)
     
  • Russell 2000 Futures

    2,182.80
    +14.20 (+0.65%)
     
  • Crude Oil

    64.23
    +0.41 (+0.64%)
     
  • Gold

    1,835.10
    +11.10 (+0.61%)
     
  • Silver

    27.36
    +0.30 (+1.11%)
     
  • EUR/USD

    1.2130
    +0.0045 (+0.38%)
     
  • 10-Yr Bond

    1.6680
    0.0000 (0.00%)
     
  • Vix

    21.76
    -5.83 (-21.13%)
     
  • GBP/USD

    1.4059
    +0.0008 (+0.05%)
     
  • USD/JPY

    109.2920
    -0.1420 (-0.13%)
     
  • BTC-USD

    50,350.25
    +43.62 (+0.09%)
     
  • CMC Crypto 200

    1,387.40
    -0.50 (-0.04%)
     
  • FTSE 100

    7,012.55
    +49.22 (+0.71%)
     
  • Nikkei 225

    28,084.47
    +636.46 (+2.32%)
     

Analyst Downgrades AstraZeneca Stock Due to Vaccine Side Effect Concerns

Cory Renauer, The Motley Fool
·2 min read
Analyst Downgrades AstraZeneca Stock Due to Vaccine Side Effect Concerns
  • Oops!
    Something went wrong.
    Please try again later.

The odds of experiencing a fatal blood clot following inoculation with AstraZeneca's COVID-19 vaccine are less than one in a million, but that was enough to spook Argus Research.